Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Inject: Insert the needle into the skin, often in the belly, thigh, or upper arm
Future GLP-1 trends: new drugs and therapies on the horizon The future of weight management may soon involve more than current GLP-1s: Amylin mimetics: These compounds mimic another satiety hormone and may complement GLP-1s. Mazdutide: A dual glucagon/GLP-1 agonist showing strong Phase 3 results and promising greater weight loss. Oral GLP-1s: Pills in development could improve convenience. Muscle-preserving combinations: Researchers are exploring co-therapies to prevent loss of lean mass during weight loss. Providers should prepare for a rapidly evolving landscape and educate patients about upcoming options. Key takeaways on GLP-1 trends for providers and patients Efficacy varies across drugs and doses
semaglutide often reduces appetite significantly, so eating less than usual is normal and expected
But fat shifts during weight loss are dependent on the person and not necessarily linked to sex, says Tan
US$ 21.80
US$ 29.88
US$ 27.72
US$ 20.48
US$ 26.33
US$ 22.42
US$ 22.94
US$ 28.47
